Financial Survey: Heart Tronics (OTCMKTS:HRTT) and Helius Medical Technologies (NASDAQ:HSDT)

Helius Medical Technologies (NASDAQ:HSDT) and Heart Tronics (OTCMKTS:HRTT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability.

Insider & Institutional Ownership

18.6% of Helius Medical Technologies shares are held by institutional investors. 17.9% of Helius Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Helius Medical Technologies and Heart Tronics”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Helius Medical Technologies	$434,000.00	3.08	-$8.85 million	($47.53)	-0.07
Heart Tronics	N/A	N/A	N/A	N/A	N/A

Heart Tronics has lower revenue, but higher earnings than Helius Medical Technologies.

Volatility & Risk

Helius Medical Technologies has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, Heart Tronics has a beta of 1047.74, indicating that its share price is 104,674% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations for Helius Medical Technologies and Heart Tronics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Helius Medical Technologies	0	1	0	0	2.00
Heart Tronics	0	0	0	0	0.00

Given Heart Tronics’ higher probable upside, analysts clearly believe Heart Tronics is more favorable than Helius Medical Technologies.

Profitability

This table compares Helius Medical Technologies and Heart Tronics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Helius Medical Technologies	-1,764.74%	-244.82%	-127.10%
Heart Tronics	N/A	N/A	N/A

Summary

Heart Tronics beats Helius Medical Technologies on 5 of the 9 factors compared between the two stocks.

About Helius Medical Technologies

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

About Heart Tronics

Heart Tronics, Inc., a medical device company, engages in the research, development, and marketing of medical devices in the United States. Its medical devices are used to monitor and measure physiological signals in order to detect diseases that impact an individual's health. The company offers Fidelity 100 Monitor System, an integrated system in which its component Model 100 Patient Module collects, processes, and amplifies electrocardiogram (ECG) signals from that patient through a set of 10 electrodes that are wirelessly transmitted to the laptop computer. Its products in the development stage include Fidelity 350 Holter Monitor, an ambulatory Holter monitor that collects ECG data of arrhythmia and transient heart disease, while the patient carries out daily activities away from the physician's office or hospital. The company's products in the development stage also consist of Fidelity 200 Event Recording System/Heart Tempo Card, a non-prescription heart monitoring device, which is used as an early-detection device by patients who desire to monitor their condition. Its products also include Cardiac Vest, a lightweight, close-fitting vest or undergarment made of stretchable material in which the electrodes are stitched into the fabric; and Fidelity 400 Intracardiac Monitor that applies its proprietary physiological signal acquisition and amplification technology to read intracardiac signals procured from intracardiac catheter. The company was formerly known as Signalife, Inc. and changed its name to Heart Tronics, Inc. in November 2008. Heart Tronics, Inc. was incorporated in 1987 is headquartered in Studio City, California.